These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31056673)

  • 1. Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response.
    Toussaint F; Hammon M; Erdmann M; Moreira A; Kirchberger MC; Schuler G; Schett G; Heinzerling L
    Rheumatology (Oxford); 2019 Oct; 58(10):1875-1877. PubMed ID: 31056673
    [No Abstract]   [Full Text] [Related]  

  • 2. Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.
    Lacombe M; Bedane C; Delaumenie S; Bernard P
    Eur J Dermatol; 2021 Dec; 31(6):844-846. PubMed ID: 34911674
    [No Abstract]   [Full Text] [Related]  

  • 3. Eosinophilic fasciitis and lichen sclerosus in a patient treated with nivolumab.
    Andrés-Lencina JJ; Burillo-Martínez S; Aragón-Miguel R; Calleja-Algarra A; Rodríguez-Peralto JL; Ortiz-Romero PL; Gargallo-Moneva V
    Australas J Dermatol; 2018 Nov; 59(4):e302-e304. PubMed ID: 29797309
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual checkpoint inhibitor-associated eosinophilic enteritis.
    Yang J; Lagana SM; Saenger YM; Carvajal RD
    J Immunother Cancer; 2019 Nov; 7(1):310. PubMed ID: 31730503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature.
    Chan KK; Magro C; Shoushtari A; Rudin C; Rotemberg V; Rossi A; Lezcano C; Carrino J; Fernandez D; Postow MA; Apollo A; Lacouture ME; Bass AR
    Oncologist; 2020 Feb; 25(2):140-149. PubMed ID: 32043775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma.
    Khoja L; Maurice C; Chappell M; MacMillan L; Al-Habeeb AS; Al-Faraidy N; Butler MO; Rogalla P; Mason W; Joshua AM; Hogg D
    Cancer Immunol Res; 2016 Mar; 4(3):175-8. PubMed ID: 26822024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic fasciitis associated with the eosinophilia-myalgia syndrome.
    Jaffe I; Kopelman R; Baird R; Grossman M; Hays A
    Am J Med; 1990 May; 88(5):542-6. PubMed ID: 2337110
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophilic fasciitis associated with L-tryptophan ingestion.
    Hamilton ME
    Ann Rheum Dis; 1991 Jan; 50(1):55-6. PubMed ID: 1994870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan-induced eosinophilic fasciitis.
    Cotsarelis G; Werth V
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):938-41. PubMed ID: 2254484
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up of patients with diffuse fasciitis and eosinophilia associated with L-tryptophan ingestion.
    Beko E; Pervaiz S; Nanda V; Dhawan S
    Cutis; 1993 Apr; 51(4):266-70. PubMed ID: 8477608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic fasciitis occurring under treatment with natalizumab for multiple sclerosis.
    Bujold J; Boivin C; Amin M; Bouchard JP; Soucy J
    J Cutan Med Surg; 2014; 18(1):69-71. PubMed ID: 24377479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic fasciitis and simvastatin.
    Choquet-Kastylevsky G; Kanitakis J; Dumas V; Descotes J; Faure M; Claudy A
    Arch Intern Med; 2001 Jun; 161(11):1456-7. PubMed ID: 11386897
    [No Abstract]   [Full Text] [Related]  

  • 13. [Eosinophilic fasciitis after taking simvastatin].
    Serrano-Grau P; Mascaró-Galy JM; Iranzo P
    Actas Dermosifiliogr; 2008 Jun; 99(5):420-1. PubMed ID: 18501180
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible association between eosinophilic fasciitis and subcutaneous heparin use.
    Cantini F; Salvarani C; Olivieri I; Padula A; Senesi C; Bellandi F; Truglia MC; Niccoli L; Palchetti R
    J Rheumatol; 1998 Feb; 25(2):383-5. PubMed ID: 9489839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbidopa-induced eosinophilic fasciitis: A review.
    Esteban-Fernandez L; Alonso-Canovas A; Rojas-Medina LM; Ballester-MartÍnez MA; Corral-Corral I; Martinez-Castrillo JC
    Neurol India; 2016; 64(1):157-9. PubMed ID: 26755008
    [No Abstract]   [Full Text] [Related]  

  • 16. Checkpoint inhibitor-associated drug reaction with eosinophilia and systemic symptom syndrome.
    Mirza S; Hill E; Ludlow SP; Nanjappa S
    Melanoma Res; 2017 Jun; 27(3):271-273. PubMed ID: 28146044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin.
    Hayashi N; Igarashi A; Matsuyama T; Harada S
    Br J Dermatol; 2000 Apr; 142(4):830-2. PubMed ID: 10792252
    [No Abstract]   [Full Text] [Related]  

  • 18. An Original Case of an Association of Eosinophilic Fasciitis with Cholangitis Induced by Nivolumab.
    Le Tallec E; Ricordel C; Triquet L; Deniel A; Marcorelles P; Lena H; Jego P; Belhomme N
    J Thorac Oncol; 2019 Jan; 14(1):e13-e15. PubMed ID: 30579548
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of L-tryptophan and an illness resembling eosinophilic fasciitis. Clinical and histopathologic findings in four patients with eosinophilia-myalgia syndrome.
    Bulpitt KJ; Verity MA; Clements PJ; Paulus HE
    Arthritis Rheum; 1990 Jul; 33(7):918-29. PubMed ID: 2369428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.